2023 PharmaPoint: Global Asthma Drug Market Growth

PharmaPoint: Asthma -
Global Drug Market
Forecast and Market
Analysis to 2023
www.bigmarketresearch.com

Report Description
Big Market Research added a new research report "PharmaPoint: Asthma - Global Drug
Forecast and Market Analysis to 2023". Asthma accounts for approximately 250,000
deaths around the world annually, deaths that otherwise could be easily prevented
through appropriate treatment The asthma market saw very slow growth over the past
decade, as it has become saturated with relatively efficacious standard therapies, such as
short-acting beta-agonists (SABAs), inhaled corticosteroids (ICSs), inhaled corticosteroids
and long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, and has also been
facing increasing generic competition. However, the launch of seven novel targeted
biologic agents and once-daily ICS and ICS/LABA therapies delivered by the nextgeneration
inhalers will strongly drive the market growth over the next 10 years. The
biologic agents will not only reshape the market growth, but will also mark the beginning
of a new era of a personalized approach to asthma treatment.
To request more information Visit @
http://www.bigmarketresearch.com/pharmapoint-asthma-global-drug-forecast-andanalysis-to-2023-market

Report Description
Key Questions Answered
• Asthma symptoms can be controlled in the majority of patients using the current
standard therapies. Nevertheless, in around 5-10% of people with asthma, the disease
remains symptomatic and inadequately controlled. Therefore, there are considerably
high unmet needs within the indication. What are the main unmet needs in this
market.Will the drugs under development fulfil the unmet needs of the asthma
market?
• The current late-stage asthma pipeline is dominated by biologics that target various
inflammatory pathways in specific patient subpopulations. Will the late-stage drugs
make a significant impact on the asthma market.What strategies are drug developers
undertaking to penetrate this difficult but potentially very lucrative market?
Feel free to get enquire about report @
http://www.bigmarketresearch.com/report-enquiry/191286

Report Description
Key Findings
• The main driver of the enormous expansion of the asthma market will be the uptake
of novel targeted biologic agents and once-daily ICS and ICS/LABA therapies in the
next-generation inhalers.
• The major global barrier for the asthma market will be the generic erosion of the
leading brands for asthma treatment, such as Advair (fluticasone
propionate/salmeterol)and Symbicort (budesonide/formoterol fumarate).

Report Description
• Companies are trying to penetrate or dominate the asthma market using two main
approaches:
1) developing drugs with different delivery devices to capitalize on long-established
off-patent therapies;
2) introducing biologics, in particular, interleukin inhibitors, to treat severe
uncontrolled asthma.
• The largest unmet needs mainly reflect the high level of heterogeneity of the disease,
the lack of patient compliance with the standard therapies, and the high cost of
medications for asthma treatment. In addition, there is a lack of diagnostic tools to
provide a reliable diagnosis of asthma in young children.

Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Disease Overview
3.1 Etiology and Pathophysiology
3.1.1 Etiology
3.1.2 Pathophysiology
3.1.3 Prognosis
3.1.4 Quality of Life
3.2 Symptoms

Table of Contents
4 Epidemiology
4.1 Disease Background
4.2 Risk Factors and Comorbidities
4.2.1 A family history of asthma is a strong predictor for asthma in children and adults
4.2.2 Puberty alters the risk for asthma in boys and girls
4.2.3 Maternal smoking during pregnancy greatly increases the risk of childhood asthma
4.2.4 Allergens are well-known asthma triggers
4.2.5 Common workplace exposures account for up to 11% of asthma cases in adults
4.2.6 Urban living conditions, not race, increase the risk of asthma by almost 50%
4.2.7 Obesity almost triples the risk of developing asthma
4.2.8 Asthmatics are 90% more likely to develop GERD
4.2.9 85% of asthmatics have allergic rhinitis
4.2.10 Panic disorders are common in asthmatics and severely impact disease control
4.2.11 39% of asthmatics are likely to develop depression

Table of Contents
4.3 Global Trends
4.3.1 US
4.3.2 France
4.3.3 Germany
4.3.4 Italy
4.3.5 Spain
4.3.6 UK
4.3.7 Japan
4.3.8 Australia
4.3.9 China
4.3.10 India
4.4 Forecast Methodology
4.4.1 Sources Used
4.4.2 Forecast Assumptions and Methods
4.4.3 Sources Not Used
4.5 Epidemiology Forecast for Asthma (2013-2023)
4.5.1 Lifetime Prevalent Cases of Asthma

Report Description
Scope
• Overview of asthma, including epidemiology, etiology, pathophysiology, symptoms,
diagnosis, and treatment guidelines.
• Annualized asthma therapeutics market revenue, annual cost of therapy and
treatment usage pattern data from 2013 and forecast for ten years to 2023.
• Key topics covered include strategic competitor assessment, market characterization,
unmet needs, clinical trial mapping and implications for the asthma therapeutics
market.

Report Description
• Pipeline analysis: comprehensive data split across different phases, emerging novel
trends under development, and detailed analysis of late-stage pipeline drugs.
• Analysis of the current and future market competition in the global asthma
therapeutics market. Insightful review of the key industry drivers, restraints and
challenges. Each trend is independently researched to provide qualitative analysis of
its implications.
Request for discount @ http://www.bigmarketresearch.com/purchase-enquiry/191286

Report Description
Reasons to buy
• Develop and design your in-licensing and out-licensing strategies through a review of
pipeline products and technologies, and by identifying the companies with the most
robust pipeline. Additionally a list of acquisition targets included in the pipeline
product company list.
• Develop business strategies by understanding the trends shaping and driving the
global asthma therapeutics market.
• Drive revenues by understanding the key trends, innovative products and
technologies, market segments, and companies likely to impact the global asthma
therapeutics market in future.

Report Description
• Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analysing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create
effective counter-strategies to gain a competitive advantage.
• Track drug sales in the global asthma therapeutics market from 2013-2023.
• Organize your sales and marketing efforts by identifying the market categories and
segments that present maximum opportunities for consolidations, investments and
strategic partnerships.

FOR MORE DETAILS
Visit us at :
http://www.bigmarketresearch.com/pharmapoint-asthmaglobal-drug-forecast-and-analysis-to-2023-market
Stay With Us:
TELEPHONE: +1 (855) 711-1555
E-MAIL: help@bigmarketresearch.com
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States